Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care. (26th October 2021)

• Record Type: Journal Article
• Authors: Jones, Jennifer L; Benchimol, Eric I; Bernstein, Charles N; Huang, James Guoxian; Marshall, John K; Mukhtar, Mariam S; Murthy, Sanjay K; Nguyen, Geoffrey C; Kaplan, Gilaad G; Kuenzig, M Ellen; Tandon, Parul; Targownik, Laura E; Windsor, Joseph W; Bitton, Alain
• Is Part Of: Journal of the Canadian Association of Gastroenterology. Volume 4(2021)Supplement 2
• Page Start: S61
• Page End: S67
• Publication Date: 2021-10-26
• Subjects: COVID-19 -- Health care delivery -- IBD -- Telemedicine; Gastroenterology -- Periodicals; 616.33005
• DOI: 10.1093/jcag/gwab034
• Languages: English
• ISSNs: 2515-2084

Abstract

Abstract: The SARS-CoV-2 pandemic has had a profound impact on inflammatory bowel disease (IBD) health care delivery. The implementation of necessary public health restrictions has restricted access to medications, procedures and surgeries throughout the pandemic, catalyzing widespread change in how IBD care is delivered. Rapid large-scale implementation of virtual care modalities has been shown to be feasible and acceptable for the majority of individuals with IBD and health care providers. The SARS-CoV-2 pandemic has exacerbated pre-existing barriers to accessing high-quality, multidisciplinary IBD care that addresses health care needs holistically. Continued implementation and evaluation of both synchronous and asynchronous eHealthcare modalities are required now and in the future in order to determine how best to incorporate these modalities into patient-centred, collaborative care models. Resources must be dedicated to studies that evaluate the feasibility, acceptability and effectiveness of eHealth-enhanced models of IBD care to improve efficiency and cost-effectiveness, while increasing quality of life for persons living with IBD. Crohn's and Colitis Canada will continue to play a major leadership role in advocating for the health care delivery models that improve the quality of life for persons living with IBD.